Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating ankylosing spondylitis

Ankylosing spondylitis and drug technology, applied in the direction of drug combination, antipyretics, anti-inflammatory agents, etc., can solve the problems of slow onset of action, achieve the effects of adjusting yin and yang, calming the property of medicine, and short course of treatment

Inactive Publication Date: 2009-08-19
闫凤宝
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Drugs that change the course of the disease, such as sulfasalazine, may control the progress of juvenile ankylosing spondylitis, but the onset of action is slow, usually within 2 to 3 months of taking the drug. Whether there is a reversal effect is still doubtful

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0059] The specific embodiment of the present invention is clinical application, described as follows:

[0060] [Case 1] Yan, male, 25 years old, suffered from ankylosing spondylitis at the age of twelve, with persistent fever and pain for four years. When his life was dying, he took the "quick-acting antipyretic Gubike" invented by himself. (Patent No.: ZL2003 101 101 533), body temperature drops to normal, active lesions are controlled, and people can get out of bed. Use powder of the present invention instead, each clothes 5 grams, day clothes three times, without untoward reaction, take recovery after two months, erythrocyte sedimentation rate and C-reactive protein also return to normal level.

[0061] [Case 2] Wang, male, 32 years old, suffered from ankylosing spondylitis five years ago. The patient has weak constitution, obstinate pain in the waist and legs, difficulty walking, night sweat and spontaneous sweating, often catches a cold, and long-term treatment is ineff...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a drug for treating ankylosing spondylitis (AS) and relates to an OTC drug of an orthopaedics, lumbocrural pain and rheumatism class. The drug consists of 33 Chinese medicines of radix polygoni multiflori preparata and the like; and the drug is processed and refined to prepare troches, capsules or pills for oral administration. The drug has mild medicine property, tonifies without causing stagnation, moistens without causing greasiness and has low cost. The drug has functions of nourishing both qi and blood, considering yin and yang, activating collaterals and relieving pain. The drug takes effect after the drug is taken for three days; a patient can recover after two months; and the drug can improve symptoms of a late patient. The drug is in particular suitable for patients with broken sclerotin and stubborn pain. After the patient recovers, the patient takes the drug to prevent diseases. The drug solves the problem that no miracle drug exists for treating AS and also has obvious treatment effect on rheumatism, rheumatoid arthritis and the like.

Description

technical field [0001] The invention relates to an internal medicine for treating low back pain, in particular to a medicine for treating ankylosing spondylitis made from pure traditional Chinese medicine. Background technique [0002] Ankylosing spondylitis is a chronic, progressive and inflammatory disease. Lesions are mainly in sacroiliac joints, spine, paraspinal soft tissue and extremity joints. The pathological changes are the ossification of the fibrous ring of the intervertebral disc and the connective tissue near the fibrous ring, the inflammation and hyperplasia of the synovial membrane of the intervertebral joints and extremities. In the late stage, bony fusion occurs in each joint, ligaments ossify, and the spine is in an ankylized state. [0003] Juvenile-onset ankylosing spondylitis can also have lesions of the skin, mucous membranes, eyes, heart, lungs, and nervous system, accompanied by some non-specific systemic symptoms, such as low to moderate fever, swe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/90A61K9/20A61K9/48A61P29/00A61P19/02A61K35/32A61K35/36A61K35/58A61K35/64A61K35/583A61K35/646
Inventor 闫凤宝
Owner 闫凤宝
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com